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A major focus of current research into gene induction relates to chromatin and nucleosomal regulation, especially the
significance of multiple histone modifications such as phosphorylation, acetylation, and methylation during this
process. We have discovered a novel physiological characteristic of all lysine 4 (K4)–methylated histone H3 in the
mouse nucleus, distinguishing it from lysine 9–methylated H3. K4-methylated histone H3 is subject to continuous
dynamic turnover of acetylation, whereas lysine 9–methylated H3 is not. We have previously reported dynamic histone
H3 phosphorylation and acetylation as a key characteristic of the inducible proto-oncogenes c-fos and c-jun. We show
here that dynamically acetylated histone H3 at these genes is also K4-methylated. Although all three modifications are
proven to co-exist on the same nucleosome at these genes, phosphorylation and acetylation appear transiently during
gene induction, whereas K4 methylation remains detectable throughout this process. Finally, we address the
functional significance of the turnover of histone acetylation on the process of gene induction. We find that inhibition
of turnover, despite causing enhanced histone acetylation at these genes, produces immediate inhibition of gene
induction. These data show that all K4-methylated histone H3 is subject to the continuous action of HATs and HDACs,
and indicates that at c-fos and c-jun, contrary to the predominant model, turnover and not stably enhanced acetylation
is relevant for efficient gene induction.
Citation: Hazzalin CA, Mahadevan LC (2005) Dynamic acetylation of all lysine 4–methylated histone H3 in the mouse nucleus: Analysis at c-fos and c-jun. PLoS Biol 3(12): e393.
Introduction
Histone modiﬁcations have been co-located to speciﬁc
genes by chromatin immunoprecipitation (ChIP) assays or by
immunocytochemistry, and ﬂowing from that, their functions
in processes involving these genes, such as epigenetic cellular
memory, silencing, and transcriptional regulation, have been
implied (reviewed in [1,2]). However, the extraordinary
biochemical susceptibility of histone tails carrying one
modiﬁcation to further modiﬁcation has received little
attention. The ﬁrst clear example of such biochemical
compartmentalisation in the mouse nucleus was the obser-
vation that all histone H3 phosphorylated at serine 10 (S10)
becomes immediately and very highly acetylated upon treat-
ment with histone deacetylase (HDAC) inhibitors sodium
butyrate [3] or Trichostatin A (TSA) [4]. This was revealed by
analysis of the modiﬁcation state of
32P-radiolabelled H3 on
acid-urea gels, in which each additional acetylation or
phosphorylation event causes an incremental shift, giving
rise to a ‘‘ladder’’ of increasingly modiﬁed H3 bands (see
Figure 1). Two aspects of this observation deserve emphasis.
First, the majority of Coomassie-stainable H3 is resistant to
TSA treatment, remaining in lower rungs of the H3 ladder on
these gels. Second, by contrast, phosphorylated H3 responds
not only quantitatively and especially sensitively to such
treatment, but rises to occupy the highest possible rungs of
the H3 ladder, indicating that on phosphorylated H3, most, if
not all, available lysines in the H3 tail become acetylated. This
shows that in mouse nuclei, blockade of HDACs results in
histone acetyltransferases (HATs) extensively modifying all
available lysines on a tiny fraction of phosphorylated H3 tails
rather than random lysine residues on all tails throughout the
nucleus.
The availability of modiﬁcation-speciﬁc antibodies for
histones H3 and H4 allowed use of ChIP assays to identify
speciﬁc genes that showed the TSA-responsive trait of
continuous dynamic acetylation. Since c-fos and c-jun
nucleosomes carried phosphoacetylated histone H3 upon
gene activation [4], these genes were tested and shown to
become hyperacetylated upon TSA treatment [5]. These
studies showed also that c-fos and c-jun nucleosomes became
hyperacetylated even when cells were not stimulated, when
these genes were inactive and not therefore carrying any
phosphorylated H3. This implied that HATs and HDACs are
constitutively targeted to these genes, causing continuous
turnover of acetylation in unstimulated cells. Further, TSA
sensitivity of phosphorylated H3 might simply be a reﬂection
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cycling nucleosomes upon stimulation of these cells.
In this paper, we ﬁrst extend characterisation of dynamic
acetylation in the mouse nucleus by analysis of H3 methyl-
ation. Histone H3 can be methylated at lysine 4 (K4) and/or
lysine 9 (K9), the former being generally associated with
active or poised genes [6–8] and the latter with repressed
genes [9,10], although it is now emerging that both
modiﬁcations can co-exist on the same genes ([11]; reviewed
in [2]). We show that all K4-methylated H3 is also subject to
dynamic acetylation, whereas K9-methylated H3 is not, a
clear and unambiguous physiological difference between
these two modiﬁcations. Further, we show that c-fos and c-
jun nucleosomes are highly methylated at K4 irrespective of
whether these genes are induced or not. Upon gene
activation, acetylation and phosphorylation co-exist transi-
ently on K4-methylated histone H3 tails at c-fos and c-jun.
Secondly, we have analysed the consequence of HDAC
blockade and hyperacetylation of these nucleosomes on the
process of c-fos and c-jun induction. Contrary to expectation,
this analysis showed that elevated acetylation does not
correspond to enhanced expression of these genes, but in
fact, inhibits their induction. This argues against the
predominant model, whereby enhanced histone acetylation
at these genes correlates with transcription, and suggests
instead that it is turnover of histone acetylation that is
relevant.
Results
Dynamic Acetylation of K4-Methylated Histone H3 in the
Mouse Nucleus
Titration experiments were ﬁrst carried out to biochemi-
cally deﬁne TSA-hypersensitive chromatin (Figure 1A).
Histones from cells treated with TSA at 1, 10, and 500 ng/
ml over a 4-h time course were analysed on acid-urea gels on
which each additional acetyl modiﬁcation causes an incre-
mental shift of H3 up the ladder. As reported previously [4,5],
the Coomassie-stained gel (Figure 1A, panel ii) showed very
little effect on bulk H3 even at high concentrations and long
TSA treatments. However, Western blotting with anti-acetyl-
Figure 1. Acetylation and Methylation of Histone H3 TSA- and TPA-Treated Cells
(A) Quiescent C3H 10T½ cells were treated with increasing concentrations of TSA (1, 10, or 500 ng/ml; 15 min to 4 h). ‘‘C’’ indicates control
(unstimulated).
(B) Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with increasing concentrations of TSA (1, 10, or 500 ng/ml; 15 min). Cells were left
unstimulated (C) or stimulated with TPA (15 to 60 min).
(C) Quiescent C3H 10T½ cells were treated with TSA (10 or 500 ng/ml; 5 min to 4 h).
Acid-soluble proteins were extracted and separated on acid-urea gels. Western blots were carried out with anti-acetyl-H3 ([A], panel i; [B], panel ii; [C],
panel v), anti-phospho-H3 ([B], panel i), anti-phosphoacetyl-H3 ([B], panel iii), anti-monomethyl-K4 H3 ([C], panel i), anti-dimethyl-K4 H3 ([C], panel ii),
anti-trimethyl-K4 H3 ([C], panel iii), or anti-dimethyl-K9 H3 ([C], panel iv) antibodies. An equivalent gel was stained with Coomassie to control for protein
loading([A],panelii; [B], paneliv; [C],panelvi). Positionsofhistoneisoformsareshownonthe rightof eachpanel,with zerobeingunmodifiedhistoneH3.
DOI: 10.1371/journal.pbio.0030393.g001
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Dynamic Acetylation of K4-Methylated H3H3 antibody (Figure 1A, panel i) clearly showed increased
acetyl-H3 at higher positions on the H3 ladder above the
major stainable H3 bands, indicating that a minute fraction
of H3 becomes fully modiﬁed. Compared to control cells, this
increase in intensity and appearance of higher acetylated H3
bands could be seen at 10 ng/ml TSA and 15–30 min time
points.
Due to occlusion by phosphate on S10, this anti-acetyl-H3
antibody only recognises H3 that is not phosphorylated (for
data, see Figure 1 of [5]; A. L. Clayton, L. C. M., unpublished
data). We also investigated early TSA-sensitive events (Figure
1B) using our (acetyl-K9/phospho-S10) phosphoacetyl anti-
body (characterised in [4]). At concentrations as low as 1 ng/
ml TSA and at the earliest time point tested, there was
extensive appearance of phosphoacetyl-H3 at the highest
positions on the H3 ladder (Figure 1B, panel iii, lane 7). This
conﬁrms previous studies discussed above that all phosphory-
lated H3 is hypersensitive to TSA-induced acetylation, with a
fraction rapidly appearing in fully acetylated form, despite
bulk Coomassie-stained H3 being largely unaffected (Figure
1B, panel iv). For all further work, we used 10 ng/ml TSA at
short time courses as deﬁnitive of TSA hypersensitivity,
although effects can clearly be seen at 1 ng/ml.
In this study, we analysed other H3 modiﬁcations for the
TSA-hypersensitive trait and found that H3 methylated at K4
falls in this category (Figure 1C). Note that methylation does
not cause any shift of histone H3 on acid-urea gels. TSA
treatment at 10–500 ng/ml resulted in rapid acetylation of K4
that was mono- (Figure 1C, panel i), di- (panel ii), and tri-
methylated (panel iii), as evidenced by progress up the H3
ladders. This effect was particularly clear with trimethylated
K4 (trimethyl-K4) H3, where appearance of higher bands
corresponded with complete loss of lower bands of the ladder
(Figure 1C, panel iii). By contrast, H3 dimethylated at K9 was
resistant to TSA. Although a small effect could be seen at
higher concentrations and later time points (Figure 1C, panel
iv), this largely correlated with the slight effect of TSA on bulk
H3, as seen in Coomassie-staining H3 bands (panel vi).
Over many similar experiments, we conclude that in the
mouse nucleus, a deﬁning characteristic of virtually all
histone H3 methylated on K4, particularly trimethyl-K4 H3,
is its TSA hypersensitivity. This indicates that most or all of
histone H3 methylated at K4 in the mouse nucleus is targeted
for continuous acetylation and deacetylation, such that
inhibition of the latter by TSA produces immediate and
extensive acetylation, exactly as described for phospho-S10
H3. Although previous analyses have localised K4- and K9-
methylated H3 at different genes, alluding to their differing
functions, this is the ﬁrst description to our knowledge of a
clear physiological distinction between histone H3 methy-
lated at these two residues.
TSA Hypersensitivity Is Targeted to Nucleosomes at c-fos
and c-jun
Previous studies have indicated that histones at c-fos and c-
jun chromatin are rapidly acetylated in the presence of high
concentrations of TSA [5]. We next used ChIP assays to ask if
TSA hypersensitivity could be observed at speciﬁc regions of
c-fos and c-jun, shown schematically in Figure 2A. Cells
treated with TSA (10 ng/ml) for 15 min to 4 h were assayed by
ChIP with anti-acetyl-H3 antibody. PCR was used to probe
immunoprecipitated DNA for speciﬁc regions of c-fos (Figure
2B, panels i–v) and c-jun (Figure 2C, panels i–v). TSA
treatment (10 ng/ml) clearly produced targeted acetylation
at these genes that was detectable, and in many cases
maximal, at the earliest time point tested (15 min), and then
dropped off to almost basal levels by 4 h (Figure 2B–2D). For
both genes, TSA-enhanced acetylation was region-speciﬁc.
For c-fos, þ132 and þ414, representing the ﬁrst exon and
intron, respectively, showed the clearest enhancement,
whereas regions that ﬂank this, i.e., the promoter,  519, and
second exon, þ1056, showed a weaker response. No increase
in acetylation was detectable further downstream at þ2622
(Figure 2B). For c-jun, apart from the region around the
transcription start site ( 110), which showed a poor response
as reported previously [5], and þ2904 at the 39 end of the
gene, the promoter ( 732) and other coding regions (þ774
and þ1608) showed very clear responses to TSA (Figure 2C).
Note that Bound/Input values for ChIP assays plotted here
(Figure 2D) are a measure of total quantitative enhancement
at each position. However, because of lower background
acetyl-H3 signal at some positions in control cells, the fold-
stimulation values between control and stimulated cells
(Figure S1) appear greatest where this background is lowest.
Because TSA does not induce these genes (see below), these
effects are unrelated to transcription. Furthermore, there was
a clear correlation between pre-existing levels of acetylation
at each region in control cells and its sensitivity to TSA
treatment. Regions with no pre-existing acetylation (fos
þ2622) showed no TSA enhancement, whereas those with
low (fos  519 and þ1056, and jun  110 and þ2904) and higher
(fos þ132 and þ414, and jun  732, þ774, and þ1608) pre-
existing levels showed TSA enhancement to intermediate and
high levels, respectively. The basal level was presumably a
reﬂection of continuous turnover at these positions. Finally,
whenever detected, TSA-enhanced acetylation was close to
maximal at early time points (15–30 min), dropping off to
return to almost basal levels by 4 h (Figure 2D), in striking
contrast to acetylation in the nucleus as a whole (see Figure
1A, panel i, lanes 7–11), which rises very strongly throughout
this period. Localised reversal of acetylation is therefore
highly gene-speciﬁc and must be mediated either by TSA-
insensitive HDACs or possibly by a histone H3 replacement
mechanism.
K4 Trimethylation of Histone H3 at c-fos and c-jun
From data in Figure 1C, TSA hypersensitivity of c-fos and c-
jun nucleosomes implies that they may also carry trimethyl-
K4 H3, veriﬁable by ChIP assays (Figure 3). Preliminary
experiments showed that trimethyl-K4 H3 antibody recov-
ered much more of these chromatin fragments than di- or
monomethyl antibodies (data not shown). Direct comparison
of regions of c-fos (Figure 3A) and c-jun (Figure 3B) recovered
by anti-trimethyl-K4 and anti-acetyl antibodies showed
remarkably that the distribution and relative levels of
trimethyl-K4 and acetylated H3 parallel each other across
these genes. Acetylation levels increased in response to TSA
treatment, whereas trimethyl-K4 levels remained unaffected
(Figure 3A and 3B, compare lanes 9–11 and 5–7). At c-fos,
both modiﬁcations were high at þ132 and þ414 and
intermediate at  519 and þ1056, but both were undetectable
at þ2622 (Figure 3A). Similarly, for c-jun, both modiﬁcations
were detectable at  732, þ774, and þ1608, but both fell to
lower levels at  110 and þ2904 (Figure 3B).
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Dynamic Acetylation of K4-Methylated H3We also performed ChIP assays to examine histone H3
acetylation and phosphoacetylation at c-fos and c-jun in 12-O-
tetradecanoyl phorbol-13-acetate (TPA)–stimulated cells.
Like many other stimuli [5], TPA produced acetylation
(Figure 3A and 3B, lanes 9 and 12) and phosphoacetylation
at these genes, with higher levels of the latter detectable in
TSA-treated cells (Figure 3C, lanes 9–12; data not shown).
Unlike acetylation and phosphorylation, which are rapidly
induced upon stimulation and gene induction, K4 H3
methylation remained detectable throughout this time course
with all stimuli tested (Figure 3; data not shown). At all
regions where it was detected, a clear K4 H3 methylation
signal was seen in unstimulated cells, and upon TPA treat-
ment alone or in combination with TSA (Figure 3C, lanes 5–8;
data not shown). This indicates that K4 H3 methylation
occurs at these genes in quiescent cells and upon stimulation,
raising the possibility that it functions as a marker to target
these regions for further modiﬁcation.
K4 Methylation of Histone H3 and TSA Hypersensitivity at
Constitutively Active and Silent Genes
We have now analysed many inducible genes (fosB, junB,
junD, and nur77; data not shown) and found all have regions
of K4 methylation and TSA hypersensitivity, the two traits
being extremely well correlated. However, the literature
shows that K4 methylation of histone H3 occurs at many
active genes, whereas many repressed silent genes are not
methylated at K4. We compared K4 trimethylation and TSA
hypersensitivity at a constitutively expressed gene and a silent
gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and b-
globin, respectively, shown schematically in Figure 4A. The
constitutively expressed GAPDH gene showed clear K4
methylation of histone H3 at  615 in the promoter and also
in coding regions of the gene, with lower levels at position
þ2095. All regions analysed were subject to TSA-hyper-
sensitive acetylation, maintaining the correlation between
H3 K4 methylation and TSA hypersensitivity (Figure 4B,
panels i and ii; data not shown). Despite these similarities,
there was a clear difference: TPA stimulation, which activates
c-fos and c-jun transcription but not GAPDH, enhanced
acetylation at speciﬁc regions of c-fos and c-jun (Figure 3A
and 3B, lanes 9 and 12), but had no effect at any position of
GAPDH tested (Figure 4B, panels i and ii, lanes 9 and 12; data
not shown). By contrast, the silent b-globin gene showed
neither H3 K4 methylation nor TSA hypersensitivity nor any
stimulus-dependent acetylation at any position analysed,
including  840 and þ261 (Figure 4B, panels iii and iv; data
not shown).
These studies revealed three characteristic types of
chromatin modiﬁcation response in these cells. Inducible
genes showed regions of H3 K4 methylation that were TSA-
hypersensitive, and in addition, stimulus-dependent gene
induction led to H3 acetylation and phosphoacetylation. The
constitutively active GAPDH gene showed H3 K4 methylation
and TSA hypersensitivity, but as might be expected, no
stimulus-dependent acetylation. And ﬁnally, the silent b-globin
gene showed none of these three characteristics. An
important observation that emerges here is the correlation
between K4 methylation and TSA hypersensitivity, which is as
yet unbroken (see Discussion).
Trimethyl-K4, Acetyl-K9, and Phospho-S10 Histone H3
Occur on the Same Nucleosome at c-fos and c-jun
Western blotting of H3 ladders on acid-urea gels (see Fig-
ure 1) showed that phospho-S10 H3 or trimethyl-K4 H3
shifted upwards upon TSA treatment, proving that acetyl
groups must co-exist on the same H3 tails carrying these
modiﬁcations. Further, the speciﬁcity of our phosphoacetyl
antibody proves that acetyl-K9 and phospho-S10 must co-
exist on the same H3 tail in stimulated cells. However, this
leaves unanswered the question of whether trimethyl-K4 and
phospho-S10 are themselves on the same nucleosome, or if
they represent two separate populations of H3 that are
independently TSA-hypersensitive.
In the absence of antibodies that recognise the triple
modiﬁcation, two approaches involving sequential immuno-
precipitation (IP) were used to ask if all three modiﬁcations
occur on the same nucleosomes at c-fos and c-jun. First, we
asked if an antibody against one H3 modiﬁcation (Figure 5,
‘‘1st IP’’) would also recover H3 with a second modiﬁcation,
depletion of the co-immunoprecipitated epitope in the
unbound fraction being veriﬁable by re-IP with a second
antibody (Figure 5, ‘‘2nd IP Unbound’’). Conversely, antibody-
bound chromatin from a ﬁrst IP was subject to a second round
of IP with a different modiﬁcation-speciﬁc antibody (Figure 5,
‘‘2nd IP Bound’’). Positions along c-fos and c-jun analysed here
correspond to peaks of modiﬁcation seen in previous ﬁgures.
To investigate co-existence of trimethyl-K4 on acetylated
H3 tails at c-fos and c-jun, chromatin from control and TSA-
treated cells were ﬁrst immunoprecipitated with trimethyl-K4
antibodies (Figure 5A). The unbound material was then
immunoprecipitated with acetyl-H3 antibodies, which
showed a marked reduction in c-fos and c-jun fragments
(Figure 5A, lanes 9–12) compared to similar anti-acetyl-H3
IPs from total chromatin (lanes 5–8). This indicates that
trimethyl-K4 H3 antibodies had sequestered acetylated H3 in
the ﬁrst round of ChIP. To prove this beyond doubt, anti-
trimethyl-K4-immunoprecipitated material was subject to a
second round of IP using anti-acetyl-H3 antibody (Figure 5A,
lanes 13 and 14). This conﬁrmed that anti-trimethyl-K4
antibody did indeed recover acetylated nucleosomes at these
positions on c-fos and c-jun, accounting for its loss from the
Figure 2. Effect of TSA Treatment on Acetylation of Nucleosomes Associated with c-fos and c-jun Genes
(A) Schematic diagram representing relative positions of regions of c-fos and c-jun amplified by primer pairs used in the PCR step of ChIP assays. Exons
are indicated by boxes, open for untranslated regions and filled for coding regions. Polyadenylation sites (pA) are indicated.
(B and C) Cross-linked chromatin fragments were prepared from quiescent C3H 10T½ cells treated with TSA (10 ng/ml; 15 min to 4 h). ‘‘C’’ indicates
control (unstimulated). Specific DNAs were immunoprecipitated with anti-acetyl-H3 antibodies. Recovered DNAs from antibody-bound fractions (AcH3
IP) as well as total input DNA (Input) from released chromatin used for ChIP were analysed for the presence of c-fos (B) and c-jun (C) gene sequences.
Controls for PCR included a DNA minus ( DNA) reaction and 5- to 20-ng loadings of input DNA to ensure all amplifications were within the linear range.
PCR reactions were carried out in triplicate and gels quantified by phosphorimaging. Representative gels are shown.
(D) Data are expressed graphically as average Bound/Input (6 standard deviation). Note that to correct for the dilution factor applied to anti-acetyl-H3
immunoprecipitated DNA prior to PCR analyses, values obtained from quantification of PCR gels were multiplied by three.
DOI: 10.1371/journal.pbio.0030393.g002
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Dynamic Acetylation of K4-Methylated H3unbound fraction. This veriﬁes Western blotting evidence
that both modiﬁcations are on the same tails and proves the
case at c-fos and c-jun.
Finally, to prove all three modiﬁcations occur on the same
nucleosomes at c-fos and c-jun, unbound and bound fractions
from control and TPA-stimulated cells, both pre-treated with
TSA, were analysed using anti-phosphoacetyl and anti-
trimethyl-K4 antibodies (Figure 5B). Cross-linked chromatin
was subject to a ﬁrst IP with anti-trimethyl-K4, and the
unbound fraction was analysed in a second IP using anti-
phosphoacetyl-H3. Compared to a direct IP using anti-
phosphoacetyl antibody, analysis of the unbound fraction
Figure 4. Histone H3 K4 Trimethylation and Acetylation at Other Genes
(A) Schematic diagram representing relative positions of regions of GAPDH and b-globin amplified by primer pairs used in the PCR step of ChIP assays.
Exons are indicated by boxes, open for untranslated regions and filled for coding regions. Polyadenylation sites (pA) are indicated.
(B) Cross-linked chromatin fragments were prepared from quiescent C3H 10T½ cells treated with TSA (10 ng/ml; 15 to 30 min) or stimulated with TPA (T;
30 min). ‘‘C’’ indicates control (unstimulated). Specific DNAs were immunoprecipitated with anti-trimethyl-K4 H3 (3K4 IP) or anti-acetyl-H3 (AcH3 IP)
antibodies. Recovered DNAs from antibody-bound fractions as well as total input DNA (Input) from released chromatin used for ChIP were analysed for
the presence of GAPDH ([B], panels i and ii) and b-globin ([B], panels iii and iv) gene sequences. DNA immunoprecipitated with anti-acetyl-H3 antibody
was diluted one in three and anti-trimethyl-K4 H3 was diluted one in 20 before PCR analyses.
DOI: 10.1371/journal.pbio.0030393.g004
Figure 3. Histone H3 K4 Trimethylation and TSA Hypersensitivity at c-fos and c-jun
(A and B) Cross-linked chromatin fragments were prepared from quiescent C3H 10T½ cells treated with TSA (10 ng/ml; 15 to 30 min) or stimulated with
TPA (T; 30 min). ‘‘C’’ indicates control (unstimulated). Chromatin fragments were immunoprecipitated with anti-trimethyl-K4 H3 (3K4 IP) or anti-acetyl-
H3 (AcH3 IP) antibodies.
(C) Cross-linked chromatin fragments were prepared from quiescent C3H 10T½ cells untreated ( ) or pre-treated with TSA (10 ng/ml; 15 min). Cells were
left unstimulated (C) or stimulated with TPA (T; 30 min). Chromatin fragments were immunoprecipitated with anti-trimethyl-K4 H3 (3K4 IP) or anti-
phosphoacetyl-H3 (PAcH3 IP) antibodies.
DNA recovered from antibody-bound fractions as well as total input DNA (Input) from released chromatin used for ChIP was analysed for the presence
of c-fos ([A]; [C], panels i and ii) and c-jun ([B]; [C], panels iii and iv) gene sequences. DNA immunoprecipitated with anti-acetyl-H3 antibody was diluted
one in three, anti-trimethyl-K4 H3 was diluted one in 20, and anti-phosphoacetyl-H3 antibody was not diluted before PCR analyses.
DOI: 10.1371/journal.pbio.0030393.g003
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Dynamic Acetylation of K4-Methylated H3after IP with anti-trimethyl-K4 clearly showed depletion of
phosphoacetyl epitope (Figure 5B, compare lanes 3 and 4
with lanes 5 and 6). Anti-phosphoacetyl antibody bound
material was then subjected to a second IP with anti-
trimethyl-K4 antibody (Figure 5B, lanes 9 and 10). This
showed that anti-trimethyl-K4 is able to recover chromatin
ﬁrst immunoprecipitated with anti-phosphoacetyl-H3 anti-
body, indicating that all three modiﬁcations are on the same
nucleosomes. Taken together, these studies prove that all
three modiﬁcations, S10 phosphorylation, K9 acetylation, and
K4 trimethylation, can certainly co-exist on the same
nucleosome, possibly on the same H3 tail, at transcriptionally
active c-fos and c-jun.
Sequential IP experiments, together with Western blotting
data, prove conclusively that all three modiﬁcations can co-
exist on the same nucleosome. It is not claimed here that all
nucleosomes at these positions along c-fos and c-jun carry all
three modiﬁcations, but rather that a sub-fraction of
chromatin fragments must carry trimethyl-K4, acetyl-K9,
and phospho-S10 to give a triply modiﬁed nucleosome. This
follows from the previously established highly dynamic
nature of acetylation and phosphorylation at these positions
[5]. The fraction that is triply modiﬁed represents a ‘‘snap-
shot’’ of a dynamic process frozen at a particular moment by
the cross-linking protocol used.
Effect of TSA Pre-Treatment on c-fos and c-jun Induction
We next investigated the functional signiﬁcance of turn-
over of histone acetylation observed above for transcriptional
activation of c-fos and c-jun. A major theme in the literature,
dating from the original discovery of histone acetylation,
suggests that enhanced acetylation correlates with more
relaxed chromatin and greater transcriptional activity. If
true, the expectation is that TSA treatment would lead to
enhanced induction of these genes. If, however, it is the
dynamic turnover of acetyl groups observed at these
nucleosomes that is critical, then inhibition of turnover with
TSA would be expected to lead to inhibited gene induction.
In preliminary studies, we found that TSA itself did not
induce these genes, but its effect on c-fos or c-jun induction by
other agents was dependent on the duration of TSA pre-
treatment. The phorbol ester TPA produces rapid, transient
activation of c-fos and c-jun in C3H 10T½ cells (Figure 6A;
[12]) and Swiss 3T3 cells (Figure S2). In both cell types, short
pre-treatment with TSA (15 min; Figure 6A, lanes 6–10;
Figure S2, lanes 4–6) inhibited TPA-stimulated induction of
both genes. By contrast, longer pre-treatment (4 h; Figure 6A,
lanes 11–15; Figure S2, lanes 7–9) produced gene-speciﬁc
effects, enhancing c-fos, but continuing to inhibit c-jun
induction. We examined the effect of short and long TSA
pre-treatment on c-fos and c-jun induction in response to
several other stimuli: EGF, bFGF, serum, and anisomycin
(Figure 6B). The inhibitory effect of short (15 min) TSA pre-
treatment on induction of these genes was very consistent
irrespective of the stimulus. By contrast, its effect after 4 h
was both gene- and stimulus-speciﬁc (Figure 6B).
Finally, we performed detailed time-course analyses (15
min to 4 h) of TSA pre-treatment to determine precisely
when the changeover from inhibition to enhancement of c-fos
induction occurs (Figure 6C). TPA-stimulated induction of
both genes was inhibited by 15 min to 1 h of TSA pre-
treatment (Figure 6C, lanes 4–12). The switch from inhibition
to enhancement of c-fos occurred between 1 and 2 h of TSA
pre-treatment (Figure 6C, panel i). Beyond 2 h, TSA clearly
enhanced TPA-stimulated c-fos expression (Figure 6C, lanes
13–20). By contrast, there was no switch to enhancement with
Figure 5. Three Histone H3 Modifications: Methylation, Acetylation, and Phosphorylation Are Targeted to the Same Nucleosome
(A) Cross-linked chromatin fragments were prepared from quiescent C3H 10T½ cells treated with TSA (10 ng/ml; 15 to 30 min) or stimulated with TPA (T;
30 min). ‘‘C’’ indicates control (unstimulated). Specific DNAs were immunoprecipitated directly (1st IP; upper line) with anti-acetyl-H3 (AcH3) or anti-
trimethyl-K4 H3 (3K4) before a second IP with anti-acetyl-H3 (2nd IP; lower line) to analyse chromatin in the anti-trimethyl-K4 H3 unbound or bound
fraction (Unbound AcH3 and Bound AcH3, respectively). DNA immunoprecipitated with anti-acetyl-H3 antibody (1st or 2nd IP) was diluted one in three
before PCR analyses.
(B) Cross-linked chromatin fragments were prepared from quiescent C3H 10T½ cells pre-treated with TSA (10 ng/ml; 15 min). Cells were unstimulated
(C) or stimulated with TPA (T; 30 min). Specific DNAs were immunoprecipitated directly (1st IP; upper line) with anti-phosphoacetyl-H3 (PAcH3) or anti-
trimethyl-K4 H3 (3K4) before a second IP (2nd IP; lower line) to analyse chromatin in the unbound or bound fraction with anti-phosphoacetyl-H3
(Unbound PAcH3), or with anti-trimethyl-K4 H3 antibodies (Bound 3K4). DNA immunoprecipitated with anti-phosphoacetyl-H3 (1st or 2nd IP) was not
diluted before PCR analyses. Recovered DNAs as well as total input DNA (Input) from released chromatin used for ChIP were analysed for the presence
of c-fos ([A], panels i and ii; [B], panels i and ii) and c-jun ([A], panels iii and iv; [B], panels iii and iv) gene sequences.
DOI: 10.1371/journal.pbio.0030393.g005
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Dynamic Acetylation of K4-Methylated H3Figure 6. Effect of TSA Pre-Treatment on c-fos and c-jun Induction
(A) Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with TSA (500 ng/ml) for 15 min (TSA 159) or 4 h (TSA 4h). Cells were left unstimulated
(C) or stimulated with TPA for 15 to 60 min, and RNA was analysed by Northern blot.
(B) Quiescent C3H 10T½ cells were untreated, or pre-treated with TSA (500 ng/ml [TPA- and EGF-stimulated cells] or 10 ng/ml [bFGF-, serum-, sAn-
stimulated cells]) for 15 min or 4 h. Cells were left unstimulated, or stimulated with TPA (T), EGF (E), bFGF (bF), serum (S), or sAn for 30 or 60 min.
(C) Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with TSA (500 ng/ml) for 15 min (TSA 159), 30 min (TSA 309), 1 h (TSA 1h), 2 h (TSA 2h), 3
h (TSA 3h), or 4 h (TSA 4h). Cells were left unstimulated (C) or stimulated with TPA for 30 or 60 min.
Northern blots in (B) and (C) were quantified by phosphorimaging, corrected for variations in loading using GAPDH, and expressed graphically. The
normal response at 30 min (c-fos)/60 min (c-jun) was set to 0%, and inhibition/enhancement in response to TSA pre-treatment expressed as a
percentage change relative to this value.
DOI: 10.1371/journal.pbio.0030393.g006
PLoS Biology | www.plosbiology.org December 2005 | Volume 3 | Issue 12 | e393 2119
Dynamic Acetylation of K4-Methylated H3longer TSA treatment for c-jun, and similar levels of
inhibition were seen over the entire time course (Figure 6C,
panel ii). Thus, in the case of c-fos, but not c-jun, a switch from
inhibition to enhancement occurred between 1 and 2 h of
TSA pre-treatment. Note that these data conﬁrm that TSA
itself does not induce c-fos and c-jun in these cells (Figure 6C,
lanes 4, 7, 10, 13, and 16; Figure 6A, lanes 6 and 11).
In further experiments, we made additional advances on
these observations. First, the early inhibitory effect on gene
induction was extremely TSA-sensitive and could be observed
at a concentration of 1 ng/ml TSA (Figure S3A). Second,
inhibition was extremely rapid, and could be observed even if
TSA and stimulus were added at the same time or indeed for
up to 5 min after stimulation of these cells (Figure S3B), but
interestingly, not 10 min after stimulation. This could
possibly be due to the very rapid peak of transcription after
stimulation, or to the possibility that once transcriptional
induction is fully initiated, TSA can no longer affect the
process. Third, we found no effect on mRNA degradation
rates under these conditions (Figure S4), indicating that
inhibition occurred at the transcriptional level, borne out by
preliminary ChIP assays using RNA polymerase II antibodies
(data not shown). Finally, we found that the later effects of
TSA (i.e., beyond 2 h), which varied depending on the gene
and stimulus studied (Figure 6B), were secondary effects
dependent on fresh translation (Figure S5), whereas the
immediate TSA effects were primary and independent of
translation. It is not possible to understand the later effects of
TSA without knowledge of why exactly translation is
required, but it is clear that they do not correlate with
enhanced histone acetylation at these genes.
Inhibition of c-fos and c-jun Induction Is a Specific
Consequence of HDAC Inhibition by TSA
To conﬁrm that the effects of TSA were directly due to
inhibition of HDACs and not due to non-speciﬁc effects of
these compounds, two approaches were taken: ﬁrst, to verify
that TSA does not affect intracellular signalling (Figure 7),
and, second, to ask if other HDAC inhibitors produce the
same effects (Figures 8A, 8B, and S6). The c-fos and c-jun
genes are critically dependent on MAP kinase cascades and
transcription factor phosphorylation for their activation.
TSA alone at 10 or 500 ng/ml did not activate any of these
MAP kinase cascades (see Figure 7A, lanes 2–13). By contrast,
TPA activated ERKs and sub-inhibitory anisomycin (sAn)
activated JNKs and p38 (Figure 7A, lanes 14–16). Further, TSA
at 10 or 500 ng/ml had no effect on TPA-induced activation of
the ERKs (Figure 7B), indicating that it does not affect any of
the several signalling steps upstream of ERKs. More critically,
we analysed TPA-stimulated phosphorylation of transcrip-
tion factors ATF-2 and CREB downstream of these cascades
and also found no effect of TSA (Figure 7C). Thus, the
inhibitory effect of TSA is unlikely to arise from any
interference with signalling to transcription factors.
As a second test that inhibition of gene induction is a direct
and speciﬁc result of HDAC inhibition, we tested three
different HDAC inhibitors that are structurally related to
TSA (MS-275, CBHA, and M344; Figure S6) and two other
inhibitors, apicidin (API) and trapoxin (TPX), that are
structurally unrelated to TSA and would not be expected to
have the same side effects as TSA (Figure 8A and 8B).
Preliminary studies determined the concentration of each
inhibitor that increased histone H3 acetylation to a level
similar to that produced by TSA (data not shown). In every
case, at these concentrations, there was a clear correlation
between the ability of each HDAC inhibitor to enhance
histone acetylation and its ability to inhibit c-fos and c-jun
induction. Treatment with TSA-related inhibitors CBHA and
M344 (Figure S6A, panel i, lanes 9–16) and API and TPX
(Figure 8A, panel i, lanes 5–8 and 14–17) produced a clear
increase in H3 acetylation comparable to that seen in TSA-
treated cells, and strongly inhibited TPA-stimulated c-fos and
c-jun induction (Figure S6B, lanes 10–15; Figure 8B, lanes 4–6
and 10–12). By contrast, treatment with MS-275, which
produced weak acetylation of histone H3 (Figure S6A, panel
i, lanes 5–8) poorly inhibited TPA-stimulated c-fos induction,
and did not inhibit c-jun (Figure S6B, lanes 7–9).
Differential Association of Specific HDACs with c-fos and
c-jun
The above data allow a hypothesis that HDACs are
speciﬁcally associated not just with upstream promoters and
enhancer elements, but also with the coding regions of these
genes even when quiescent, thereby explaining turnover of
acetylation at these positions. To test this hypothesis, we used
antibodies against speciﬁc HDACs (HDAC1 and HDAC3–
HDAC7) in ChIP assays using quiescent cells, analysing both
promoter and coding regions of these genes. Using these
antibodies, the clearest and most reproducible associations
with these genes were obtained with anti-HDAC1, 3, 4, and
 6 antibodies (Figure 8C; data not shown). HDAC6 was found
to be associated with the coding region and promoter of both
c-fos and c-jun (Figure 8C, lane 9). We also observed coding-
region-speciﬁc association of HDAC4 for both c-fos and c-jun,
but not at the promoters of these genes (Figure 8C, lane 8;
data not shown). HDAC1 and HDAC3 were only seen at the c-
fos coding region and were not detected at c-jun (Figure 8C,
lanes 2 and 5). This shows that several HDACs can be found
speciﬁcally associated with particular regions of c-fos and c-
jun, which can account for the continuous turnover of histone
acetylation that we report here. Due to the lower recovery of
chromatin fragments using these HDAC antibodies, we may
only have been able to detect the most abundant HDACs
present at speciﬁc regions and cannot rule out the presence
of other HDACs at these regions.
Discussion
Turnover of acetyl groups on histone tails [13] has been a
contentious issue since the discovery of acetylation (reviewed
in [14]). Metabolic labelling of bulk histones suggests at least
two populations with very fast (half-life of 1–5 min) and
moderately fast (half-life of 30–60 min) turnover rates
(reviewed in [14]). ChIP-based analyses of yeast promoters
reveal localised transient histone acetylation associated with
remodelling [15], as well as rapid targeted reversal of
acetylation after removal of either acetylase (deacetylation
within 1.5 min) or deacetylase (acetylation restored in 5–8
min) from a promoter [16]. This model of dynamic rather
than stable modiﬁcation in yeast is supported by the
association of the HDAC Hos2 with coding regions of active
genes [17]. Evidence of very fast turnover of acetyl groups on
a sub-fraction of histones in mammalian cells came from
metabolic-labelling studies of phosphorylated H3, which
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Dynamic Acetylation of K4-Methylated H3Figure 7. Effect of TSA Pre-Treatment on TPA-Stimulated MAP Kinase Activation and Transcription Factor Phosphorylation
(A) Quiescent C3H 10T½ cells were treated with TSA (10 or 500 ng/ml; 5 min to 4 h). Positive controls for MAP kinase activation included ERK1/2 (TPA [T];
10 min), JNK/SAPKs, and p38 (sAn; 30 to 60 min). ‘‘C’’ indicates control (unstimulated). Cell extracts were analysed by Western blotting with anti-ERK1/2,
anti-phospho-p38, and anti–ACTIVE JNK antibodies. The mobility of ERKs is retarded on activation. Activation of p38 and JNK/SAPK results in
phosphorylation. Note that anti–ACTIVE JNK also recognises activated ERK1/2 (lane 14).
(B) Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with TSA (10 or 500 ng/ml; 15 min). Cells were then left unstimulated (C) or stimulated
with TPA for 5 to 30 min. Cell extracts were analysed by Western blotting with anti-ERK1/2 antibody.
(C) Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with TSA (500 ng/ml; 15 min). Cells were stimulated with TPA for 15 to 30 min. Cell
extracts were analysed by Western blotting with anti-ATF-2 and anti-phospho-CREB antibodies. Phosphorylation of ATF-2 results in retarded mobility.
DOI: 10.1371/journal.pbio.0030393.g007
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Dynamic Acetylation of K4-Methylated H3Figure 8. Specificity of Inhibition and Association of HDACs with Regions of c-fos and c-jun
(A) Quiescent C3H 10T½ cells were treated with TSA (10 ng/ml) and HDAC inhibitor API or TPX for 15 min to 4 h. ‘‘C’’ indicates control (unstimulated).
Acid-soluble proteins were extracted and separated on acid-urea gels. Western blots were carried out with anti-acetyl-H3 antibodies (panel i). A
representative gel was stained with Coomassie to indicate protein loading (panel ii). Positions of histone isoforms are shown on the right of each panel,
with zero being unmodified histone H3.
(B) Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with TSA (10 ng/ml) and HDAC inhibitor API or TPX for 15 min. Cells were then left
unstimulated (C) or stimulated with TPA for 30 or 60 min. RNA was analysed by Northern blot.
(C) Cross-linked chromatin fragments were prepared from untreated quiescent C3H 10T½ cells. Specific DNAs were immunoprecipitated with anti-
HDAC1, anti-HDAC3, anti-HDAC4, or anti-HDAC6 antibodies. Recovered DNAs from antibody-bound fractions as well as total input DNA (Input) from
released chromatin used for ChIP were analysed for the presence of c-fos (panels i and ii) and c-jun (panels iii and iv) gene sequences.
DOI: 10.1371/journal.pbio.0030393.g008
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Dynamic Acetylation of K4-Methylated H3rapidly shifts to the highest acetylated forms upon HDAC
inhibition [3].
Detailed analysis of the effects of TSA and other HDAC
inhibitors on histone H3 acetylation and c-fos and c-jun
induction here has produced two surprising results. First,
these analyses show very highly targeted TSA hypersensitivity,
uniquely targeted to all phospho-S10 and methyl-K4, but not
dimethyl-K9, H3 in the mouse nucleus. These multiply
modiﬁed TSA-hypersensitive nucleosomes have been local-
ised to speciﬁc regions on c-fos and c-jun, indicating that these
genes are subject to continuous acetylation and deacetylation
irrespective of transcription. Second, inhibition of deacety-
lases at these genes rapidly enhances histone acetylation but
inhibits transcription; contrary to the predominant view that
increased histone acetylation is characteristic of enhanced
transcription. Our data suggest an alternative model, whereby
turnover of acetyl groups on K4- methylated histone H3 tails
is both characteristic of the poised c-fos and c-jun genes, and
is required for their efﬁcient induction.
Differential Sensitivity of Nuclear Events to HDAC
Inhibition
Classiﬁcation of TSA sensitivity in the mouse nucleus
would have TSA-insensitive genes such as b-globin (see Figure
4) at one extreme, followed by a broad swathe of TSA-
responsive events, including many in the literature for which
high levels of TSA and long treatments are required (see
Table S1). Within this second category, data presented here
raise the serious complication that some TSA-responsive
phenomena, e.g., enhanced c-fos induction after 4 h of TSA
pre-treatment (see Figure 6A), are secondary events requiring
fresh translation (see Figure S5), unrelated to the state of
acetylation at the gene, which by 4 h has subsided (see Figure
2). At the other extreme, TSA-hypersensitive genes can be
deﬁned as those at which the TSA effect is virtually
instantaneous, requiring low concentrations of TSA and
detectable by immediate localised histone acetylation. This
provides both a molecular model of localised cycling
acetylation at these genes, as well as an experimental
deﬁnition for their detection: brief treatment with TSA
followed by ChIP using acetyl-speciﬁc antibodies recovers
chromatin containing these genes. Here, to our knowledge
for the ﬁrst time, we have demonstrated TSA hypersensitivity
directed towards all K4-methylated H3 in the mouse nucleus
but not K9-methylated H3. Furthermore, K4-methylated
TSA-hypersensitive histone H3 occurs at the poised c-fos
and c-jun genes irrespective of transcription, as well as at the
continuously transcribed GAPDH (polymerase II) and 18S
rRNA (polymerase I) genes, but not at a gene transcribed by
RNA polymerase III (tRNA) or silenced in these cells (b-globin;
see Figures 3 and 4; data not shown). This raises the
possibility, discussed further below, that K4 methylation acts
as a prior mark that renders histone H3 particularly
susceptible to HATs and/or TSA-sensitive HDACs. In yeast,
support for this model comes from the recent observation
that SAGA and SLIK histone acetyltransferase-containing
complexes also contain the chromodomain-containing pro-
tein Chd1 that binds to K4-methylated histone H3 [18].
Owing to differential sensitivity of individual HDACs to
inhibition with TSA ([19]; reviewed in [20]), effects seen at the
lowest concentrations used here are likely mediated by
HDACs particularly sensitive to TSA, with other HDACs
becoming involved at higher concentrations. Furthermore,
we do not exclude the possibility that acetylation of non-
histone proteins may also contribute to the inhibition of c-fos
and c-jun seen here. We failed to detect such non-histone
acetylation events using various anti-acetyllysine antibodies,
but this may be because of limitations of reagents or
sensitivity of techniques used. However, the highly targeted
enhancement of histone acetylation speciﬁcally at c-fos and c-
jun offers an obvious and local cause for their inhibited
induction. Until any non-histone acetylation events can be
demonstrated at these genes, the simplest interpretation is
that the proven histone acetylation shown here is responsible
for these observations.
Deployment of Histone-Modifying Enzymes to Produce
Dynamic Acetylation of K4-Methylated Histone H3
TSA-hypersensitive chromatin and K4-methylated H3 must
be under continuous opposed action of HATs and HDACs
implying micro-compartmentalisation of HAT and/or HDAC
function in mammalian nuclei. An H3 K4 methyltransferase
must also be directed to these same nucleosomes, but because
K4 methylation at these genes appears stable in all the
experiments described here and over longer time courses
through the cell cycle (data not shown), it is not clear when K4
methylation is deposited, an issue currently under inves-
tigation. These two targeted modiﬁcations, methylation and
the turnover of acetylation, are constitutive in quiescent cells
and differ from the third modiﬁcation, phosphorylation, in
not requiring activation of signalling cascades or gene
induction.
Localised dynamic turnover of acetylation may be ex-
plained by physical distribution of HATs and HDACs in three
conceivable ways: (1) HATs are tightly restricted while
HDACs act in a diffuse global way, (2) HDACs are tightly
restricted while HATs act in a diffuse global way, or (3) both
enzymes are tightly co-localised to these genes. It is unlikely
that HATs act in a diffuse global mode, as there is much
evidence that protein–protein interactions with transcription
factors target HATs to genes. Local recruitment of HATs such
as CREB-binding protein (CBP), p300, and PCAF via
interactions with CREB, SRF, and Elk-1 at regulatory
elements upstream of c-fos [21,22], and with c-Jun, ATF-2,
and MEF upstream of c-jun, have been described [23,24].
Association of pre-assembled Elk-1/CBP complexes with gene
promoters such as c-fos in the absence of transcriptional
activation has been demonstrated, but CBP activation is
reported to require MAP kinase signalling and Elk-1
phosphorylation [21,25]. Our data show that HATs act
continuously, irrespective of cell stimulation or transcription
at these genes. Furthermore, TSA-induced acetylation occurs
not just at promoter nucleosomes but also more distantly in
the body of the gene, as far as ten nucleosomes away for c-jun
and four nucleosomes away for c-fos, but not across the entire
transcribed region in either case (see Figure 2). Although
there are HATs in RNA pol II holoenzyme and elongation
complexes [26], turnover of acetylation occurs independently
of transcription and, furthermore, also occurs in upstream
non-transcribed regions.
Although targeted HATs alone might explain TSA hyper-
sensitivity, it is likely that HDACs are also targeted to these
genes. This has been studied in Saccharomyces cerevisiae by
deleting speciﬁc HATs and HDACs and using ChIP assays to
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Dynamic Acetylation of K4-Methylated H3analyse effects on histone acetylation either at speciﬁc loci or
globally using microarrays [27–29]. These results show that
both HATs and HDACs are targeted in yeast, and further,
that there is ‘‘division of labour’’ among HDACs [28], e.g.,
HDAC Sir2p at telomeres, Rpd3p at centromeres, Hos1p and
Hos3p at ribosomal DNA, and Hos2p at ribosomal protein
genes. For c-fos in mammalian cells, mSin3A-HDAC co-
repressor complex is reported to be recruited via interactions
with Elk-1 [30] but this requires ERK activation and is
proposed to mediate shut-off after induction.
Co-location of K4 methylation with H3 acetylation might
be implied from the association of both with active tran-
scription (reviewed in [1,2]). Some of the most interesting
recent work co-locates H3 acetylation directly with K4
methylation at the same regions of the genome and on the
same H3 tail, or places the relevant enzymes in the same
complexes. Liang et al. [31], using an adaptation of ChIP
assays, found H3 acetylation and K4 methylation around the
transcription start sites of several active genes in human
bladder cancer cells. H3 has been found on active genes in
Drosophila euchromatin hyperacetylated and hypermethylated
on K4 and K27 [32]. Bradbury and colleagues [33,34], using
mass spectrometry, showed that H3 tails that are K4-
methylated are also likely to be hyperacetylated, an important
study that, unlike the majority of ChIP assays that address
localisation to speciﬁc regions on a gene, deﬁnitively places
multiple modiﬁcations on the same H3 molecule. Relating to
enzyme complexes, the tethering of an HDAC Sin3 to a
Trithorax-related K4 methyltransferase (Set1/Ash2) is re-
ported to be mediated by host cell factor-1 (HCF-1) in
human cells [35]. Finally, the TAC1 chromatin-modifying
complex in Drosophila contains the K4 methyltransferase
Trithorax and the HAT CBP ([36]; reviewed in [37]).
Gene Induction and Histone Modifications in the Mouse
Nucleus
A major advantage of our mouse model system is that c-fos
and c-jun are poised to transcribe and can be readily induced.
Using this system, we ﬁnd no strict correlation between the
K4 methylation state and transcriptional activity. Spatially,
K4 methylation spans the start site and extends in both
directions at active or poised genes; upstream regions that
are not transcribed are K4-methylated, whereas regions
furthest downstream that can be transcribed are not K4-
methylated. Furthermore, K4 methylation is present whether
the gene is constitutively active (GAPDH), poised to transcribe
(c-fos and c-jun in control cells), or induced to transcribed (in
stimulated cells), but is absent in a constitutively silent gene
(b-globin). This removes any strict link between K4 methyl-
ation and the progress of RNA polymerase II across a gene in
mouse cells. Instead, what is established are ‘‘islands’’ of K4
methylation spanning the start sites, whose key characteristic
is the continuous turnover of acetylation by the action of
HATs and HDACs. Induction of c-fos and c-jun causes
transient MAP-kinase-mediated phosphorylation at S10 on
these H3 tails as well as a shift in the HAT/HDAC equilibrium
to favour acetylation. Importantly, blocking turnover of
acetylation results in inhibited c-fos and c-jun induction.
These two changes are transient whereas pre-existing K4
methylation at these positions remains detectable for many
hours afterwards. Temporarily, therefore, a proportion of
nucleosomes at these positions on c-fos and c-jun can be
formaldehyde-ﬁxed in a state where they simultaneously
carry methyl-K4, acetyl-K9, and phospho-S10 on the same H3
tail. One of the key advances of this work is that it removes
comprehensively the notion that ‘‘active’’ genes in the mouse
nucleus differ in histone modiﬁcation from ‘‘inactive’’ genes
in a stable and deﬁnable way, but highlights instead the highly
dynamic nature of these modiﬁcations and regional varia-
tions across genes. This study, in common with a recent high-
resolution histone modiﬁcation mapping study in yeast [38],
challenges the idea of a ‘‘histone code’’ differentiating active
from inactive genes.
Materials and Methods
Cell culture and stimulation. C3H 10T½ and Swiss 3T3 mouse
ﬁbroblasts were grown in DMEM with 10% FCS. Conﬂuent cultures
were quiesced by incubation for 16–18 h in DMEM containing 0.5%
FCS. Pre-treatment refers to addition of TSA at the times indicated
prior to stimulation and left on throughout the period of stimulation
until harvest. Cells were pre-treated with histone deacetylase inhibitor
TSA (1–500 ng/ml [3.3 nM–1.65 lM]; Sigma, St. Louis, Missouri, United
States), API (0.5 lM [39]; Alexis Biochemicals, Montreal, Quebec,
Canada), or TPX (500 ng/ml [40]; kindly provided by B. M. Turner,
University of Birmingham) and then stimulated with TPA (100 nM;
Sigma), EGF (50 ng/ml; Promega, Fitchburg, Wisconsin, United States),
bFGF (20 ng/ml; Roche, Basel, Switzerland), 15% FCS (Invitrogen,
Carlsbad, California, United States), or sAn (25 ng/ml; Sigma).
Northern blot analysis of RNA. Gene expression was analysed by
Northern blotting as described previously [41]. Blots were sequen-
tially hybridised to c-fos and c-jun probes and then to the loading
control GAPDH. Northern blots were visualised by autoradiography
and quantiﬁed using a PhosphorImager (Molecular Dynamics,
Sunnyvale, California, United States).
Analysis of proteins by Western blotting. Extraction of histones,
acid-urea polyacrylamide gel electrophoresis, and Western blotting
were carried out as described previously [4,42]. Antibodies were used
at the following dilutions: anti-phospho-H3 and anti-phosphoacetyl-
H3, 1:1,000; anti-acetyl-H3, 1:2,000; anti-monomethyl-K4 H3, 1:500;
anti-dimethyl-K4 H3, 1:2,500; anti-trimethyl-K4 H3, 1:2,000; and anti-
dimethyl-K9 H3, 1:2,000. Protein extraction and gel electrophoresis
for analysis of MAP kinase activation was carried out as described
previously [12,43]. Antibody speciﬁcity is described in Protocol S1.
Chromatin immunoprecipitation. ChIP was performed using
formaldehyde cross-linked chromatin as described previously [4]
with modiﬁcations [5]. ChIPs were carried out using 5 lg of anti-
acetyl-H3 antibody/500 ll of chromatin, 25 lg of anti-phosphoacetyl-
H3/500 ll of chromatin, and 5 ll of anti-trimethyl-K4 H3/200 llo f
chromatin. ChIP analyses using HDAC antibodies were performed
using dimethyl adipimidate (Pierce Biotechnology, Rockford, Illinois,
United States) and formaldehyde cross-linked chromatin as described
in Protocol S1, and 10 ll of anti-HDAC1,  3,  4, or  6/500 llo f
chromatin. To analyse unbound chromatin after primary ChIP,
unbound supernatant chromatin was removed and retained after
incubation with protein A–Sepharose beads (Sigma), and a different
second antibody used in ChIP. Sequential ChIPs were performed to
analyse histone H3 tails carrying multiple modiﬁcations. After
primary ChIP, antibody-bound chromatin isolated by binding to
protein A–Sepharose was washed and eluted as described previously
[4]. Eluted chromatin was diluted to 0.1% SDS, adjusted to RIPA
buffer and pre-cleared by incubation with protein A–Sepharose
beads for 2 h at 4 8C with rotation. After pre-clearing, the
supernatant was concentrated using Vivaspin concentrators (50,000
MWCO; Vivascience, Hannover, Germany). A second ChIP was then
carried out using a different antibody. The speciﬁcity of antibodies
used in ChIPs is detailed in Protocol S1. Quantitative radiolabelled
PCR products resolved on 6% polyacrylamide-TAE gels were
visualised by autoradiography and quantiﬁed by phosphorimaging
[4]. Input DNA was diluted one in 60 to approximately 1 ng/ll, and 5
ll was used per PCR reaction. To ensure signals were within the
linear range, DNA recovered using anti-acetyl-H3 was diluted one in
three and anti-trimethyl-K4 H3 one in 20, and anti-phosphoacetyl-H3
was used undiluted for PCR analyses [5]. DNA recovered using HDAC
antibodies was also used undiluted for PCR analyses. Primer names
relate to the 59 position of the forward primer relative to the
transcription start site. Details of regions ampliﬁed by primers used
in this study and sequences of primers are provided in Protocol S1.
PLoS Biology | www.plosbiology.org December 2005 | Volume 3 | Issue 12 | e393 2124
Dynamic Acetylation of K4-Methylated H3Similar results were obtained in at least two separate experiments.
Quantiﬁed PCR data, from PCRs performed in triplicate, are
presented as Bound/Input, which corrects for variations in input
loading and gives an indication of the relative abundance of
immunoprecipitated DNA sequences.
Supporting Information
Figure S1. Increased Acetylation of Nucleosomes Associated with c-fos
and c-jun Genes on TSA Treatment
Chromatin fragments were immunoprecipitated with anti-acetyl-H3
antibodies (see Figure 2). Recovered DNAs from antibody-bound
fractions (AcH3 IP) as well as total input DNA (Input) from released
chromatin used for ChIP were analysed for the presence of c-fos (A)
and c-jun (B) gene sequences. Quantiﬁed PCR data, from PCRs
performed in triplicate, are presented here as fold-induction. Note
that in contrast to presenting data as Bound/Input (see Figure 2D),
which is a measure of the relative abundance of immunoprecipitated
DNA sequences, fold-induction shows changes in the level of
acetylated H3 on TSA treatment at speciﬁc regions of c-fos and c-
jun. Fold-induction appears highest at regions displaying lower basal
levels of acetylation. This can be misleading as there can be much
greater amounts of acetylation at other regions, as shown by the
Bound/Input graphs in Figure 2.
Found at DOI: 10.1371/journal.pbio.0030393.sg001 (40 KB PDF).
Figure S2. Effect of TSA Pre-Treatment on c-fos and c-jun Induction
in Swiss 3T3 Cells
Quiescent Swiss 3T3 cells were untreated ( ) or pre-treated with TSA
(500 ng/ml) for 15 min (TSA 159) or 4 h (TSA 4h). Cells were left
unstimulated (C), or stimulated with TPA for 30 or 60 min, and RNA
was analysed by Northern blot.
Found at DOI: 10.1371/journal.pbio.0030393.sg002 (52 KB PDF).
Figure S3. TPA-Stimulated c-fos and c-jun Induction Is Hypersensitive
to TSA Pre-Treatment
(A) Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with
increasing concentrations of TSA (0.01, 0.1, 1, 10, 100, or 500 ng/ml)
for 15 min. Cells were left unstimulated (C) or stimulated with TPA
for 30 or 60 min.
(B) Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with
TSA (10 ng/ml) for 15 min ( 159), 5 min ( 59), or 0 min (09), and then
stimulated with TPA for 30 or 60 min; or cells were ﬁrst stimulated
with TPA, and then TSA (10 ng/ml) was added after 2.5 min (þ2.59), 5
min (þ59), 10 min (þ109), or 15 min (þ159); cells were then harvested
after 30 or 60 min of TPA treatment. RNA was analysed by Northern
blot.
Found at DOI: 10.1371/journal.pbio.0030393.sg003 (59 KB PDF).
Figure S4. Effect of TSA Pre-Treatment on c-fos and c-jun mRNA
Stability
Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with
TSA (500 ng/ml) for 15 min (TSA 159). Cells were stimulated with TPA
(þ) for 30 min before the addition of DRB to block transcription.
Cells were harvested from 0 to 30 min after DRB addition. As a
control for transcriptional inhibition, DRB treatment for 5 min prior
to TPA stimulation (30 min) was included. ‘‘C’’ indicates control
(unstimulated). Northern blots were quantiﬁed by phosphorimaging,
corrected for variations in loading using GAPDH, and expressed
graphically (panels i and ii). The response at TPA 30 min/DRB 0 min
was set to 100%, and the rate of mRNA decay expressed relative to
this value.
Found at DOI: 10.1371/journal.pbio.0030393.sg004 (52 KB PDF).
Figure S5. Effect of the Translational Inhibitor Emetine on TSA-
Mediated Changes in TPA-Stimulated c-fos and c-jun Induction
Quiescent C3H 10T½ cells were untreated, or pre-treated with TSA
alone (TSA; 500 ng/ml), emetine alone (Em), or emetine plus TSA (Em
þ TSA) for 15 min or 4 h. Cells were left unstimulated, or stimulated
with TPA for 30 or 60 min. Northern blots were quantiﬁed by
phosphorimaging, corrected for variations in loading using GAPDH,
and expressed graphically. Values for c-fos and c-jun mRNA from
control untreated cells were negligibly low. The normal TPA response
at 30 min (c-fos)/60 min (c-jun) was set to 0%, and inhibition/
enhancement in response to TSA/emetine pre-treatment expressed as
a percentage change relative to this value.
Found at DOI: 10.1371/journal.pbio.0030393.sg005 (35 KB PDF).
Figure S6. Effect of Different HDAC Inhibitors on Histone H3
Acetylation and c-fos and c-jun Induction
(A) Quiescent C3H 10T½ cells were treated with TSA (10 ng/ml) and
HDAC inhibitor MS-275, CBHA, or M344, for 15 min to 4 h. ‘‘C’’
indicates control (unstimulated). Acid-soluble proteins were ex-
tracted and separated on acid-urea gels. Western blots were carried
out with anti-acetyl-H3 antibodies (panel i). A representative gel was
stained with Coomassie to indicate protein loading (panel ii).
Positions of histone isoforms are shown on the right of each panel,
with zero being unmodiﬁed histone H3.
(B) Quiescent C3H 10T½ cells were untreated ( ) or pre-treated with
TSA (10 ng/ml) and HDAC inhibitor MS-275, CBHA, or M344, for 15
min. Cells were then left unstimulated (C) or stimulated with TPA for
30 or 60 min. RNA was analysed by Northern blot.
Found at DOI: 10.1371/journal.pbio.0030393.sg006 (64 KB PDF).
Protocol S1. Additional Experimental Procedures
Found at DOI: 10.1371/journal.pbio.0030393.sd001 (59 KB DOC).
Table S1. Examples of Different TSA Concentrations and Treatment
Times
Found at DOI: 10.1371/journal.pbio.0030393.st001 (50 KB DOC).
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